We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Thromboelastography Applied in Diagnosing Normal and Complicated Pregnancies

By LabMedica International staff writers
Posted on 04 May 2022

During pregnancy, the coagulation system in women undergoes considerable changes to prevent bleeding. More...

If the coagulation system in pregnant women is not functioning optimally, incidents such as bleeding and miscarriage are prone to occur; if the coagulation system in pregnant women is hyperfunctional, the risk of venous thrombosis is high.

At present, many indicators such as activated partial prothrombin time and prothrombin time are used to detect blood coagulation function in the body. Thromboelastography (TEG), as a currently accessible laboratory test, can reflect the dynamic changes in the coagulation process and has high application value in evaluating platelet function.

Hematologists at the Affiliated Hospital of Hubei Polytechnic University (Huangshi, China) collected samples for 156 pregnant women with normal pregnancy (NP) and 58 women with threatened abortion (TA), 13 with missed abortion (MAb), 25 with embryo arrest (EA), four with fetal death (FD), six with a history of abnormal pregnancy (HAP), and seven with antiphospholipid antibody syndrome (AA).

TEG was performed using a BVCA-I thromboelastometer. The parameters R, K, α-angle, MA, LY-30, G, and coagulation index (CI) were analyzed. Partial correlation analysis was used to analyze correlation between groups of data. LSD-t test and Dunnett's T3 test were used to analyze continuous variables. Ordinal categorical variables were compared using ordinal logistic regression analysis and estimate odds ratio of risk factors. A receiver operating characteristic (ROC) curve was constructed to detect the ability of TEG to recognize various parameters, and areas under the curve were compared using Delong's test for diagnosing pregnancy-related diseases.

The scientists reported that there was no correlation between the data of NP and TA, and NP and FD groups; MAb had a negative effect on the MA parameter in TEG; EA had a negative effect on the MA and G parameters; HAP had a negative effect on the CI parameter and a positive effect on the R parameter; AA had a negative effect on the CI parameter. The team found that TEG parameters were different between some patient groups and control groups. For example, the CI value of the TA group was decreased, and the ratio of the angle value lower than the upper limit of the normal reference value was higher than that of the NP group, indicating that the coagulation function is low, and there could be a problem of inadequate fibrin levels or function.

The authors concluded that TEG has a good clinical significance in the diagnosis of TA, MAb, EA, AA, and HAP. The study was published on April 24, 2022 in the Journal of Clinical Laboratory Analysis.

Related Links:
Affiliated Hospital of Hubei Polytechnic University


New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Rapid Sepsis Test
SeptiCyte RAPID
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay GenoPredicta, which is intended for comprehensive genomic characterization of hematologic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.